PFE

NYSE

PFIZER INC

Health Care, Pharmaceuticals

$26.76

close 7 Aug 2026

+8.87%

52-week change

$152.52B

market cap

$23.58

$28.75

52-week range

Expected price

$10.51 – $12.85

Current price

$26.76

Signal

Could be overvalued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)35.21x

P/S (TTM)2.39x

P/B1.79x

EV/EBITDA (TTM)15.96x

FCF yield (TTM)7.20%

PEG (TTM, GAAP)—

Context

P/E, own 5-year average18.49x

P/E, sector median29.65x*

Price at 5-year median P/E$11.40*

Indicated dividend yield6.43%

Forward — analyst consensus

Forward P/E (FY2026)9.01x*

Forward P/E (FY2027)9.29x

Forward PEG—*

Consensus EPS FY2026 (24 analysts)$2.97

EPS growth (FY2026→FY2027)-2.97%

Revenue growth (FY2026)-0.71%

Street view

Price target (mean)$28.63*

Target upside7.00%

Ratings (buy / hold / sell)10 / 16 / 2

FY2026 EPS revisions, 30d (up / down)5 / 6

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 28 Jun 2026, filed 4 Aug 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR -5.71%10Y CAGR -3.74%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$26.76

Cash & equivalents$976.00M

Total debt$63.10B

Shares outstanding5.70B

Result

DCF price per share$8.19

Current price$26.76

Margin of safety-69.41%

PV of years 1–10$56.11B

PV of terminal value$52.67B

Equity value$46.66B

Market-implied growth+3.11%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$10.36B	$9.77B	$9.21B	$8.68B	$8.19B	$7.72B	$7.28B	$6.86B	$6.47B	$6.10B	$113.71B
PV	$9.59B	$8.37B	$7.31B	$6.38B	$5.57B	$4.86B	$4.25B	$3.71B	$3.24B	$2.83B	$52.67B

period to 28 Jun 2026, filed 4 Aug 2026, close 7 Aug 2026